Author:
Abston Eric,Farber Harrison W.
Subject
Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine
Reference6 articles.
1. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2;Galie;Circulation,2008
2. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications;Gubbins;Clin. Pharmacokinet.,1991
3. LC-ESI-MS/MS method for quantification of ambrisentan in plasma and application to rat pharmacokinetic study;Nirogi;Biomed. Chromatogr.,2012
4. Pharmacokinetics of ambrisentan, a novel drug for treatment of pulmonary arterial hypertension (PAH) in Japanese subjects;Nakahara;Jpn. J. Clin. Pharmacol. Ther.,2010
5. Ambrisentan;Frampton;Am. J. Cardiovasc. Drugs,2011